Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 21.48% vs 16.73% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 314.42% vs 124.21% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 224.93% vs 10.28% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 84.95% vs 42.36% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Shin Nippon Biomedical Laboratories, Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -30.54% vs 76.22% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 21.48% vs 16.73% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -53.78% vs 92.24% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 314.42% vs 124.21% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -49.93% vs 40.94% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 224.93% vs 10.28% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 20.65% vs 13.30% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 84.95% vs 42.36% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






